Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer | MicrobiomeTrials← Back to trialsNCT06929468
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-01-20Est. Completion: 2027-06
Enrollment target: 55 participants Locations- Klinikum Nuremberg, Nuremberg, Bavaria, Germany
Other microbiome trials you might be interested in
Sudden Sensorineural Hearing Loss (SSNHL)
Total-type sudden sensorineural hearing loss (defined in this study as severe-to-profound sudden sensorineural hearing l…
Guangzhou, ChinaEst. completion Sep 30, 2029
CancerChemo BrainChemotherapyHearing
This project aims to understand how platinum-based chemotherapy affects hearing function in cancer patients from differe…
Lancaster, United KingdomEst. completion Sep 1, 2028